X

XBiotech

D
XBIT
USD
0.41
(5.4594%)
Market Closed
1,662.00
Volume
EPS
-
Div Yield
-6.827586
P/E
241,268,195.52
Market Cap
Today
5.4594%
1 Week
16.987%
1 Month
23.557%
6 Months
10.769%
12 Months
74.066%
Year To Date
96.770%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments

Title:
XBiotech

Sector:
Healthcare
Industry:
Biotechnology
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Do you need help or have a question?
Contact Us